Arkolith/Insider Trading/ADAP/Form 4

Menzel Garry E

DirectorAdaptimmune Therapeutics PLC (ADAP) · full profile →Form 4 · filed Jul 5, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
0 non-derivative · 7 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 5, 2023Grant(A)2.7M—$02.7M
Jul 5, 2023Grant(A)58K—$058K
Jul 5, 2023Grant(A)3.6M—$03.6M
Jul 5, 2023Grant(A)360K—$0360K
Jul 5, 2023Grant(A)1.3M—$01.3M
Jul 5, 2023Grant(A)737K—$0737K
Jul 5, 2023Grant(A)2.2M—$02.2M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-078195) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML